Pliant (United States)

company in South San Francisco, United States

PLRX Nasdaq ISIN US7291391057 SEC CIK 1746473
Follow Pliant (United States) Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$24.4M +7.3% vs same quarter last year
EPS, diluted −$0.39 +9.3% vs same quarter last year
Operating cash flow −$17M +19.5% vs same quarter last year
Operating income −$25.7M +8.9% vs same quarter last year
Net income by quarter
$370.9M
−$56.2M
−$43.3M
−$26.3M
$275.1M
−$20M
−$22.4M
−$24.4M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−$150M−$100M−$50M$0$50M$100MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$0-
FY24$0-
FY23$1.6M-
FY22$9.7M−$123.3M
FY21$7.6M−$97.3M
FY20$41.8M−$41.5M
FY19$57.1M−$631K
FY18--
MarginsShare of revenue
  • Operating margin
  • Net margin
−15000%−10000%−5000%0%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearOperating marginNet margin
FY25--
FY24--
FY23−11654.7%-
FY22−1313.4%−1273.3%
FY21−1288.1%−1284.5%
FY20−99.6%−99.3%
FY19−2.2%−1.1%
FY18--
Free cash flowOperating cash flow minus capital expenditure
−$200M−$150M−$100M−$50M$0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$128.7M
FY24−$159.4M
FY23−$117.3M
FY22−$96.4M
FY21−$77.4M
FY20−$38.8M
FY19−$3.7M
FY18-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Pliant (United States)
  • Healthcare median
−1500%−1000%−500%0%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearPliant (United States)Healthcare median
FY25-−30.6%
FY24-−47%
FY23-−58%
FY22−1273.3%−80.4%
FY21−1284.5%−71.8%
FY20−99.3%−62.2%
FY19−1.1%−46.2%
FY18-−49.6%